| Report ID | 282921 |
| Drug Identification Number | 02457040 |
| Brand name | LABETALOL HYDROCHLORIDE INJECTION |
| Common or Proper name | LABETALOL HYDROCHLORIDE INJECTION |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 x 20mL vial / fiole |
| ATC code | C07AG |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-05-15 |
| Actual start date | |
| Estimated end date | 2026-06-01 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | [email protected] - 1-800-363-0584 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-15 | French | Compare |
| v1 | 2026-04-15 | English | Compare |
Showing 1 to 2 of 2